iBio (IBIO) Net Margin Growth (5y) (2016 - 2025)
iBio (IBIO) Net Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -381,659.00 |
| Jun 30, 2025 | -209,730.00 |
| Dec 31, 2024 | 590,303.00 |
| Jun 30, 2024 | -201,512.00 |
| Sep 30, 2023 | 857,600.00 |
| Mar 31, 2022 | 995,761.00 |
| Sep 30, 2021 | -398,735.00 |
| Jun 30, 2021 | 98,384.00 |
| Mar 31, 2021 | -20,875.00 |
| Dec 31, 2020 | 51,833.00 |
| Sep 30, 2020 | -72,154.00 |
| Jun 30, 2020 | 27,735.00 |
| Mar 31, 2020 | -449,040.00 |
| Dec 31, 2019 | -739,620.00 |
| Sep 30, 2019 | -400,585.00 |
| Jun 30, 2019 | -1,362.00 |
| Jun 30, 2018 | -470,887.00 |
| Sep 30, 2017 | -272,324.00 |
| Jun 30, 2017 | -237,305.00 |
| Mar 31, 2017 | -1.01 Mn |